» Articles » PMID: 23685557

Understanding the Effects of Tobacco Smoke on the Pathogenesis of Aortic Aneurysm

Overview
Date 2013 May 21
PMID 23685557
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Aneurysmal arterial disease is a vascular degenerative condition that is distinct from atherosclerotic and other occlusive arterial diseases. There is regionalization of the predisposition to aneurysm formation within the vascular tree, and the pathological process varies with location. Infrarenal abdominal aortic aneurysm (AAA) is the most common manifestation of aneurysmal disease, and smoking is the dominant risk factor. Smoking is a much greater risk factor for AAA than for atherosclerosis. In addition to playing a role in the pathogenesis of AAA, smoking also increases the rate of expansion and risk of rupture of established AAA. The mechanistic relationship between AAA and smoking is being established by the use of enhanced animal models that are dependent on smoke or smoke components. The mechanisms seem to involve durable alterations in vascular smooth muscle cell and inflammatory cell function. This review examines the clinical, epidemiological, and mechanistic evidence implicating smoking as a cause of aneurysms, focusing on AAA.

Citing Articles

Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies-A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension.

Mancusi C, Basile C, Fucile I, Palombo C, Lembo M, Buso G High Blood Press Cardiovasc Prev. 2025; .

PMID: 40082374 DOI: 10.1007/s40292-025-00710-3.


Integrative Bioinformatics Analysis to Identify Key Ferroptosis-Related Genes and Immune Infiltration in Aortic Aneurysm and Dissection: Implication of PTGS2.

An W, Luo J, Zhang C, Xiao Q J Inflamm Res. 2025; 18:1377-1394.

PMID: 39897521 PMC: 11787787. DOI: 10.2147/JIR.S488651.


Cross-sectional study of lung cancer patients as a potential high-risk factor for abdominal aortic aneurysm.

Gwon H, Woo A, Yong S, Park Y, Kim S, Kim E PLoS One. 2025; 20(1):e0315898.

PMID: 39761267 PMC: 11703101. DOI: 10.1371/journal.pone.0315898.


Rare vascular complications in classical Ehlers-Danlos syndromes.

Chong C, Chaudhuri D, Varikara K BMJ Case Rep. 2025; 18(1.

PMID: 39755536 PMC: 11751598. DOI: 10.1136/bcr-2024-260109.


New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review.

Alsabbagh Y, Erben Y, Vandenberg J, Farres H J Pers Med. 2024; 14(12).

PMID: 39728062 PMC: 11677056. DOI: 10.3390/jpm14121148.


References
1.
Lindholt J, Jorgensen B, Shi G, Henneberg E . Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2003; 25(6):546-51. DOI: 10.1053/ejvs.2002.1872. View

2.
Finlay G, ODriscoll L, Russell K, DArcy E, Masterson J, Fitzgerald M . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997; 156(1):240-7. DOI: 10.1164/ajrccm.156.1.9612018. View

3.
Shapiro S . Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2001; 21(4):621-32. DOI: 10.1016/s0272-5231(05)70172-6. View

4.
Norman P, Spilsbury K, Semmens J . Falling rates of hospitalization and mortality from abdominal aortic aneurysms in Australia. J Vasc Surg. 2010; 53(2):274-7. DOI: 10.1016/j.jvs.2010.08.087. View

5.
Pardo A, Gaxiola M, Uhal B, Becerril C, Selman M . Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000; 117(3):684-94. DOI: 10.1378/chest.117.3.684. View